THE RUSSELL GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BARRON | — |
Pharmacy PHA
Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BARRON | — |
| TYSON REDPATH | — |
| RANDALL RUSSELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.